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A pattern recognition quantitative structure-activity relationship (QSAR) study has been performed to determine 
the molecular features of carbamate anticonvulsants which influence biological activity. Although carbamates, such 
as felbamate, have been used to treat epilepsy, their mechanisms of efficacy and toxicity are not completely 
understood. Quantum and classical mechanics calculations have been exploited to describe 46 carbamate drugs. 
Employing a principal component analysis and multiple linear regression calculations, five crucial structural 
descriptors were identified which directly relate to the bioactivity of the carbamate family. With the resulting 
mathematical model, the biological activity of carbamate analogues can be predicted with 85-90% accuracy. 
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INTRODUCTION 
The underlying mechanisms of action for the 
agents used to treat epilepsy are incompletely 
understood. For example, felbamate (2-phenyl- 
1,3-propanediol dicarbamate), a newly-developed 
potential anticonvulsant, has an unknown mecha- 
nism of actionim5; moreover, a number of patients 
who received this medication died from either 
hepatoxicity or aplastic anemia6. Thus, just as its 
mechanism of efficacy is unknown, felbamate’s 
mechanism of toxicity has likewise not been 
elucidated’-‘. A thorough molecular-level study 
of felbamate and other carbamates may shed 
light on these mechanisms. Quantitative 
structure-activity relationship (QSAR) studies 
are a technique which aid in identifying the 
structural features which are responsible for 
biological activity. This process, in turn, has the 
potential to uncover possible mechanisms of 
action for efficacy and toxicity’. Therefore, the 
focused goal of this study is to perform a pattern 
recognition QSAR on carbamate anticonvulsants 
to identify the bioactive pharmacophore, i.e. the 
three-dimensional arrangement of atoms within a 
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carbamate fragment capable of producing desired 
anticonvulsant biological effects. 
The pattern recognition approach to QSAR 
attempts to determine reasons for biological 
activity in some compounds and inactivity in 
others within the same drug class. This approach 
assumes the following: (1) a wide variety of a 
drug’s physical and chemical properties can be 
reduced to numerical quantities, termed 
descriptors’, (2) the descriptors which influence 
activity can be determined and calculated’ and (3) 
a mathematical relationship between the descrip- 
tors and the compound’s biological activity can be 
described”,’ ‘. This knowledge assists in the early 
stages of research as the therapeutic potential of a 
given class of compounds is investigated. The 
simplicity of some of the descriptors and the 
availability of high-powered computers for calcu- 
lating the large number of equations facilitate 
this in-depth structural analysis. In a competitive 
market, sensitive, yet economical devices are of 
great importance. In this study, a set of 
carbamates is thoroughly described and a 
mathematical model is developed which predicts 
the activity or inactivity of individual analogues 
against an animal model of epilepsy. 
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MATERIALS AND METHODS 
Background to methods 
The correlation of biological activity with mole- 
cular structure is central to modem neurophar- 
macology and enables an enhanced mechanistic 
understanding of drug action at the molecular 
level of reality. Accordingly, contemporary 
approaches to the study and design of bioactive 
molecules are based on the notion that bioactivity 
may be related quantitatively to molecular 
structure through the application of QSAR 
techniques’2-‘4. The establishment of QSAR 
relationships for anticonvulsants has been hin- 
dered by the chemical diversity of the moelcules 
and by the complexity of the physiological and 
biochemical processes that initiate and propagate 
seizure activity. 
A vareity of QSAR techniques are available, 
including free energy models (Hansch 
equation15”6), mathematical models (Free- 
Wilson equation”), statistical models” (dis- 
criminant analysis, cluster analysis), quantum 
mechanics and molecular mechanics methods”, 
topological methods2’ and pattern recognition 
methods2’-24. In recent years, the pattern recog- 
nition technique described by Stuper and Jurr?‘, 
Kirschner and Kolalski26 and Wold et al”*24 has 
emerged as one of the most all-encompassing 
and versatile techniques. 
The initial objective of this theoretical pattern 
recognition study was to identify a theoretical 
‘classification rule’ capable of correctly categoriz- 
ing carbamate compounds into pharmacologically 
active and inactive classes based solely upon an 
examination of their structural properties. This 
problem was approached in two stages. First, a set 
of carbamates of known biological activity was 
selected and designated as the ‘training set’. A 
group of theoretical ‘descriptors’ was then gener- 
ated to describe each compound in this training 
set. Statistical techniques (regression analyses) 
were then employed to identify the minimal 
number of descriptors (i.e. the ‘essential descrip- 
tor set’) capable of distinguishing active from 
inactive carbamates. This essential descriptor set 
constitutes a classification algorithm or rule. This 
classification rule was next applied to a second set 
of carbamates, termed the ‘test set’, to evaluate 
the validity and predictability of the rule. As a 
corollary to developing a classification rule which 
designated activity from inactivity, it was possible 
through complementarity arguments, to identify a 
molecular fragment (i.e. ‘the bioactive fragment’) 
which constituted the region of structural com- 
monality among active anticonvulsants. 
The selection of descriptors capable of com- 
pletely encoding the significant and structural 
aspects of carbamate molecular structure was 
crucial. The carbamate numbering scheme is 
shown in Fig. 1. The descriptors are listed in 
Table 1, and are catagorized into four classes: 
geometric, electronic, topological and physio- 
chemical (42 descriptors were employed in this 
study). Geometric descriptors represent three- 
dimensional properties and reflect aspects of 
molecular shape and size. The geometric descrip- 
tors employed in this study were derived from 
theoretical quantum mechanics and molecular 
mechanics calculations. The carbamate analogues 
under study were conformationally and geomet- 
rically optimized using the AM1 Hamiltonian 
after a preliminary scanning of their conforma- 
tional space using multiple molecular mechanics 
force field optimizations. Electronic descriptors 
such as charge densities, bond moments, orbital 
energies and frontier electron densities, reflect 
molecular properties arising from variable el- 
ectron distribution through a compound’s str- 
uctural framework. The electronic descriptors 
used in this study were obtained from the 
Mulliken population analyses of theoretical AM1 
semi-empirical quantum mechanics calculations. 
Topological descriptors encode aspects of mole- 
cular composition and connectivity, and describe 
patterns of interatomic interconnections that 
determine ultimate molecular architecture. The 
topological descriptors used in this study were 
derived from graph theory calculations2635. In 
graph theory calculations, a graph G is a 
(a) 04 (b) 0 
(c) 
-1 
Cb’ 
CH-CH.--0 
AN/H 
Fig. 1: Carbtimate numbering scheme. Representations of 
the carbamates evaluated in the study. The generalized 
form is represented by A while f3 and C represent specific 
analogues Cl and C2, respectively. 
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Table 1: List of descriptors 
Geometric descriptors (from AM1 semi-empirical 
calculations) 
1-3 Bond lengths 
NI-C2,C2-03,C2-04. 
4-6 interatomic distances 
Nl -R, Nl - Rl, Nl - R2. 
7-9 Bond angles 
Nl-C2-03,Nl-C2-04,03-C2-04. 
10 Torsional angle 
Nl -C2-03-04. 
Electronic descriptors (from AMI semi-empirical 
calculations) 
1 I-14 Atomic charge densities 
Nl, C2, 03. 04. 
15-16 Molecular dipole moments 
17 Heath of formation 
18 E HOMO-LUMO 
Topological descriptors (from graph theory calculations) 
19-20 Zagreb topological indices 
M,. M2 
21 Piatt topological index 
22-29 Randic topological indices 
‘x, 2x, ‘x, Jx 
txv, *xv, TX‘., “xv 
30-32 Volume of the substituents 
Voi R, Vol R, + R,, Vol R + R, + R,. 
33 Number of carbon atoms in molecule 
34 Number of oxygen atoms in molecule 
35 Number of haiide atoms in molecule 
36 Number of rings in molecule 
37 Number of atoms in molecule 
38 Number of hydrogen atoms in molecule 
39 Number of double bonds in molecule 
40 Number of triple bonds in molecule 
41 Molecule weight of molecule 
Physicochemical descriptor 
42 Lipophilicity of molecule 
loe. P 
mathematical structure consisting of vertices 
(atoms) connected by edges (bonds). The 
mathematical structure that maps a certain 
molecule (molecular graph G) is the adjacency 
matrix A[G]. For an N-atom molecule, A[G] is an 
N X N matrix with entries aij having values of 
either 1 or 0, since any two atoms in a given 
molecule are in binary relation being either 
connected or not connected. Physiochemical 
descriptors, such as the partition coefficient 
(1% I-7 describe molecular lipophilicity, 
representing the ability of a drug to traverse 
biological membrane barriers. 
Calculations were done using both classical and 
quantum mechanical methods. New conceptual/ 
computational methodologies are permitting 
pharmacologically useful studies to be achieved 
using quantum mechanics and classical mechan- 
ics. Quantum mechanics is a non-empirical 
method in which the properties of a stationary 
state of a molecule are obtained by solution of 
the Schrodinger partial differential equation: 
W = W, where H is the Hamiltonian 
differential operator and Ic, is the wave function. 
Molecular quantum mechanics calculations may 
be ab initio or semi-empirical. Semi-empirical 
calculations use a simpler Hamiltonian than the 
correct molecular Hamiltonian and incorporate 
additional parameters designed to fit experimen- 
tal data. In contrast, ab initio calculations use the 
full correct Hamiltonian and attempt a solution 
through a rigorous first principles treatment. 
Classical mechanics force field calculation is 
conceptually quite different: it is an empirical 
technique which employs multiple classical equa- 
tions of motion to provide a priori geometries for 
varying conformations of large molecules. The 
sum of the individual classical equations constit- 
utes a multi-dimensional potential energy func- 
tion (termed the ‘force field’), which expresses 
the restoration forces acting on a molecule when 
the minimum potential energy conformation is 
perturbed. By minimizing the force field equa- 
tion, it is possible to determine the lowest energy 
native conformation of a large biomolecule. 
Application of methods to carbamate QSAR 
The biological activity data for the carbamate 
fa’mily were obtained from published literature 
source?‘. The compounds were subdivided into 
groups designated ‘active’ (bioactivity = 1) or 
‘inactive’ (bioactivity = 0) as determined using a 
maximal electroshock assay. Seventy-five per cent 
of the compounds were randomly selected for 
inclusion in the training set and the remainder of 
the molecules became the test set (which was then 
reserved for the validation of discovered predic- 
tive models”). Table 2 contains the training and 
test set assignments. All molecules were then 
structurally optimized. 
All optimizations were perfromed on an IBM 
RS/6000 RISC 355 processor using Spartan 
modelling software3’ operating under the AIX 
Windows operating system. The compounds were 
first optimized using molecular mechanics (MM) 
calculations, with Sybyl force fields, and were 
further optimized using AMl, a semi-empirical 
quantum mechanical method, to obtain the 
geometric and electronic descriptors. The topolo- 
gical descriptors were calculated using a PC- 
based program38 while log P values were deter- 
mined by ClogP3’. The substituent volumes were 
calculated utilizing fragment values from Motoc 
and Marshal14’. A PCA computer program4’ 
operating on the IBM RS/6000 RISC 355 
processor was employed in the data reduction 
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Table 2: Carbamate analogues 
ID# R Rl 
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R2 Activity 
Training set 
Cl 
c2 
c3 
c4 
C5 
C6 
Cl 
C8 
c9 
Cl0 
Cl1 
Cl2 
Cl3 
Cl4 
Cl5 
Cl6 
Cl7 
Cl8 
Cl9 
c20 
c21 
C22 
C23 
C24 
c25 
C26 
C27 
C28 
C29 
c30 
Test set 
Tl 
T2 
T3 
T4 
T5 
T6 
T-7 
T8 
T9 
TlO 
Tll 
T12 
T13 
T14 
T15 
T16 
i-C3H7- 
i-C4H9- 
set-C4H9- 
n-C5Hl l- 
n-C3H7CH(CH3)- 
tert-C5Hl l- 
Cl+CC(CH=CH2)(CH3)- 
n-C4H9CH(CH3)- 
Cl+CC(CH=CH2)(CH=CHZ)- 
C6HSCH2- H 
C6H5CH2CH2- H 
C2H5- C6H5- 
C6H5CH(C2H5)- H 
C2H5 C6HSCHZCH(CH 
n-C6H13- C6H5CH2- 
C2H5- C6H5- 
C2H5- Cl3CCH(OH)- 
(CH3)2C(CH20H)CH2- H 
(C2H5)2C(CH20H)CHZ- H 
n-C3H7C(CH3)(CH20H)CH2- H 
(C2H5)2C(CH20H)CH2- CH3- 
n-C4H9C(CZH5)(CH20H)CH2- H 
o-CH3C6H5OCH2CH(OH)CH2- H 
CSHSC(C2HS)(CH2OH)CH2- H 
I I 
p- 
I I 
o-CH3C6H4OCH2CH(OH)CH2- 
o-CH30C6H40CHZCH(OH)CH2- 
CkCC(CH3)(CH=CHCI)- 
C2H5 
tert-C4H9 
(C?.H5)2CH- 
CMC(CH=CH2)(i-C2H7)- 
C6H5CH(CH3)- 
(C6H5)2CH- 
C6H5CH2- 
(C2H5)2C(CH20H)CH2- 
o-CH~OC~H~OCH~CH(OH)CH~- 
(C6H5)2C(CH20H)CH2- 
H 
H 
H 
C6H5- 
C6H5- 
H 
H 
H 
H 
H 
H 
H 
C6H5- 
CH3- 
H 
H 
C6H5- 
H 
C6H5CH2- 
H 
H 
o-CH3C6H40CH2CH(CH20-i-C3H7)- H 
H 
H 
H 
H 
H 
H 
H 
H 
C6H5- 
H 
H 
H 
H 
CH3- 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
1 
1 
1 
0 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
0 
0 
0 
1 
0 
1 
1 
1 
1 
1 
1 
1 
0 
0 
1 
1 
1 
1 
1 
1 
0 
0 
1 
,l 
1 
0 
1 
0 
1 
1 
1 
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stage. All other calculations were perfromed on 
an IBM compatible PC using Quattro ProTMJ2. 
RESULTS 
Data analysis 
An initial multiple linear regression (MLR) could 
only be perfromed on descriptors which were 
completely uncorrelated, i.e. descriptors which 
are ‘orthogonal’ to each other. To address this 
problem, a principal components analysis (PCA) 
was used to transform correlated descriptors into 
new, orthogonal descriptors which were linear 
combinations of the original descriptors4”A”. The 
refurbished descriptors of the training set were 
employed to develop a predictive model by the 
‘leave-one-out’ method, which also functions as a 
technique for cross-validation46.‘7. This method 
involves performing a MLR on all the compounds 
except for one. A model was then developed and 
implemented to predict the activity of the 
compound which was originally omitted46. This 
process was repeated while each compound was 
left out sequenitally and systematically. The 
PRESS (PRedicted Error Sum of Squares) 
recorded the error between the true and pre- 
dicted activities of each trial. PRESS(i) = (at - 
a:)*, where ai is the true or measured activity and 
a; is the predicted activity of the ith compound. 
The smaller the PRESS, the more precise the 
prediction. The total PRESS indicated the error 
in ability of the models to predict the individual 
members of the training set. When the values for 
a; were rounded off to 1 or 0 the PRESS equalled 
zero for a correctly predicted activity and the 
PRESS equalled one for an incorrect prediction’. 
A summary table was constructed to illustrate the 
results. Once it was confirmed that the individual 
models were promising, an average model was 
derived and re-applied to the entire training set. 
New PRESS values were recorded. If this model 
predicted well (i.e. had a low PRESS value), then 
the model was applied to each of the compounds 
belonging to the test set while the errors were 
monitored. 
When these steps were followed with forty-two 
descriptors, the predictive ability was significant. 
However, there was a need to reduce the number 
of descriptors to increase the chemical sig- 
nificance of the findings. 
Data reduction 
The correlation matrix of the initial 42 descriptors 
revealed a high degree of correlation between 
various descriptors. Only one descriptor from 
each highly correlated pair was selected for 
further analysis”. Chemical rationalization was 
used to decide which descriptor should be 
eliminated. For example, the direct correlation 
between the Vol R, + Rz and the N, - CZ bond 
length was not surprising since the larger the 
volume of the substituent, the further away N, 
will pull from the rest of the molecule to alleviate 
any steric hindrance. Accordingly, N, - C2 was 
dropped in favour of the volume parameter. If 
there was not an apparent chemical rationaliza- 
tion, the degeneracy index was consulted. The 
degeneracy index, D%, indicates the ability to a 
given parameter to discriminate between 
different compounds3’; therefore, since the de- 
scriptor with the better discernment has the lower 
the index value, the descriptor with the smaller 
D% was retained. The number of descriptors was 
reduced- initially from forty-two to twenty-eight 
and then to thirteen and tinahy to ten by this 
method. Based on additional information from 
crystallographic studies4x.4” and from documented 
ab initio” experiments on carbamates, the num- 
ber of descriptors was successfully reduced to 
five. Table 3 outlines which descriptors were 
retained at each stage. A separate PCA and series 
of leave-one-out trials, as well as an assessment of 
the precision of the average model on the training 
and test sets respectively were perfromed at each 
level to confirm the effectiveness of the elimina- 
tion of the descriptors. 
The trials with five transformed descriptors 
yielded the mathematical model with optimal 
predictive ability (see Table 3). Since the number 
of descriptors had been reduced to five and there 
were thirty compounds in the training set, the 
QSAR ‘rule of thumb’ is achieved whereby there 
should be at least four compounds for every 
independent variable for the ‘chance of correla- 
tion risk to be acceptably 10~‘~‘. Thus a MLR 
perfromed on the raw data is justified; however, 
the raw data must first be ‘auto-scaled’, i.e. 
re-scaled to the same (unit) variance giving each 
variable the same opportunity at the onset to 
influence the MLR result’***. The following 
equation was determined: 
Activity = - 0.019 G-0, + 0.054 N, 
- 0.057 Dipole - 0.072 Vol R 
- 0.285 vol RI + R2 + 0.781. 
The average error of the prediction (i.e. 
average PRESS) of bioactivity for the training 
and test sets were 0.100 and 0.126, respectively, or 
10.0% and 12.6%. 
Since the coefficients of the MLR are derived 
from autoscaled data, ideal absolute values for 
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Table 3: Descriptors used for each model 
28 Descriptors 
NI-C2, 
cz-03. CT?-04. 
NI-R, NI-RI. 
Nl-R2. 
N I --Q-03, 
Nl-CZ-04, 
03-C2-04. 
N 1 -C2-03-04 
NI. C2. 03. 
04. 
Dipole moment. 
H,. ~,MO.LL~MO~ 
‘X”. Vol R. 
Vol R,-R,, 
Vol total. 
Number C. 
Number ol 
rings. number 
H. 
total atoms. 
double bonds, 
13 Descriptors IO Descriptors 
C2-03, C2-04. CZ-03. (J-04. 
N I-R2. 
03-C2-04. 03-C2-04. 
N I -C-Z-03-04 N I -C2-03-04 
Nl. 04. Nl. 04. 
Dipole momenr. Dipole moment, 
HP H,. 
‘IX”‘. Vol R. Vol R, 
Vol R, - R>. Vol RI-R,. 
MW 
8 Descriptors 7 Descriptors 6 Descriptors 5 Descriptors 
CZ-03. CZ-04. ““‘, C2-04. CZ-04. a-04. 
03-CZ-04. 03-(x-04. 
,.I”, 
(.lX.40, 
Nl. Iw1 NI. Nl. NI. 
Dipole moment, Dipole moment. Dipole moment. Dipole moment, 
H,. 6. HP 
Vol R. Vol R. Vol R. Vol R. 
Vol R,-R2. Vol R,-RI. Vol R,-RZ, Vol R,-R2. 
the physical descriptors cannot be readily 
identified. A negative coefficient suggests that a 
measurement for a given descriptor which is small 
relative to the values of the compounds in the 
training set will have a greater chance of being 
biologically active than one with an extremely 
large value. Conversely, a positive coefficient 
indicates that values which are relatively large for 
the corresponding descriptor will be favoured. 
DISCUSSION 
Five descriptors are significant for predicting the 
anticonvulsant activity of carbamates: the Cz-0, 
bond length, the electronic charge on the N, 
atom, the dipole moment of the molecule and the 
volumes of R (the ’ I)-substituent’) and R, + R2 
(the ‘N-substituents’-refer to Fig. 1 for the 
carbamate numbering scheme). 
The volume of the substituents (Vol R and 
Vol R, + R,) is a crucial factor in the activity or 
inactivity of the compound, suggesting a space- 
limiting feature for the biological mechanism. If a 
substituent is too large the molecule will not 
interact effectively with the receptor site; if it is 
too small the compound will not be in simul- 
taneous contact with all of the necessary regions 
of the receptor to promote activity. The C,-0, 
bond length may also affect how the molecule 
docks into a particular site. 
The electrostatic descriptors are similarly im- 
portant in ascertaining a compound’s ability to 
bind to a receptor. Because of the inherently 
subjective nature of charge partitioning methods, 
the absolute atomic charges calculated from a 
semi-empirical protocol lack rigorous physical 
meaning . 52 However, the consideration of the 
relative atomic charges between compounds may 
be valuable, and is particularly so, as the model 
suggests, with respect to the N, charge. The 
dipole moment of the molecule may also lead to 
information about site specific receptor binding. 
Log P values are often identified as crucial 
descriptors” because of their direct link to a 
compound’s capacity to cross the blood-brain 
barrier; the larger the log P value, the greater the 
molecule’s ability to cross the membrane. How- 
ever, in this investigation, the combined volume 
of the N-substituents (R, and R,) was found to 
correlate directly with the log P values. There- 
fore, during the data reduction stage, the log P 
value was eliminated as a descriptor because the 
R, and R2 volumes which were also highly 
correlated with several other descriptors could 
account for the same information more succinctly 
within a MLR analysis. 
Calculations such as those presented in this 
study may be of value in designing future 
carbamate analogues as improved anticonvul- 
sants. For example, from the MLR equation, a 
carbamate analogue with optimally small Q- and 
N- substituents would have a greater degree of 
biological activity than one with large sub- 
stituents. (However, if the substituent is too 
small, the drug will not be lipophilic enough to 
cross the BBB). A reduction of the dipole 
moment would also favour bioactivity; therefore, 
the substituents ought to be able to ‘diffuse’ the 
electron density of the -OC(=O)N- function- 
ality. To meet this need, a compact electron 
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withdrawing group could be included within the 
ester substituent (R substituent), such that the 
size requirements are not greatly compromised. 
The presence of a hydroxyl group, for instance, 
while minimizing the over-all dipole moment, 
could also offer some potential hydrogen bonding 
to a receptor site, although the model does not 
specifically recognize this mechanism. 
These calculations are also of value in provid- 
ing indirect insights concerning receptor struc- 
ture. For example, this information suggests that 
the carbamate receptor site has volume limita- 
tions, a situation which is generally favourable 
and which leads to more precise binding. (There 
would need to be several exposed functional 
groups which would serve as hydrogen bond 
donors and acceptors.) A lipophilic pocket 
7-10 A in length would also be required to 
accommodate the I)-substituent. The entire 
pocket of the receptor site, basedeon the present 
data, should be no more than 15 A long. 
Although the developed model utilizing five 
descriptors possesses a high ability to predict the 
biological activity of carbamates, there are 
refinements which could be included. Generally, 
in the training set there should be a minimum of 
10 compounds representing each class and there 
should be an equal representation among 
classes”. In the test set, there should also be an 
even distribution of active and inactive com- 
pounds. In this study, however, there were 22 
active and only eight inactive compounds in the 
training set while the test set contained 13 active 
and three inactive analogues. For these results to 
be unquestioned statistically, more data will have 
to be accumulated, particularly that which iden- 
tifies inactive carbamate molecules. 
CONCLUSIONS 
The investigation into the structural parameters 
of carbamates has confirmed that the physical and 
chemical aspects, as evidenced by the biological 
activity, of the molecules are closely linked. By 
following standard statistical methods and man- 
ipulating simple descriptors obtained from semi- 
empirical calculations and from volume fragment 
tables, the biological activity of carbamate com- 
pounds can be predicted with a great degree of 
accuracy and precision. The standard PCA for 
data reduction and a subsequent MLR analysis 
revealed that a reduced volume of the sub- 
stituents, a smaller CZ-0, bond length, a weaker 
dipole moment, and a smaller negative charge on 
the nitrogen atom are crucial factors in producing 
a positive biological effect. The positive results 
from this experiment suggests that further studies 
should be perfromed to statistically confirm or 
refine the predictive model. The structure of the 
ideal, biologically active carbamate could be 
improved, which might then lead to a better 
understanding about potential receptor sites. 
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